INCREASE IN CLONOGENIC TUMOUR CELLS IN BONE MARROW OF PATIENTS WITH MULTIPLE MYELOMA TREATED WITH VINCRISTINE, DOXORUBICIN, AND METHYLPREDNISOLONE
- 1 October 1988
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 332 (8617) , 931-933
- https://doi.org/10.1016/s0140-6736(88)92599-8
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- In vitro studies of ways to overcome resistance to VAMP‐high dose melphalan in the treatment of multiple myelomaBritish Journal of Haematology, 1989
- A simple method for culturing myeloma cells from human bone marrow aspirates and peripheral blood in vitroBritish Journal of Haematology, 1988
- The development of high dose melphalan and of autologous bone marrow transplantation in the treatment of multiple myeloma: Royal Marsden and St Bartholomew's hospital studiesHematological Oncology, 1988
- Multiple myeloma treated with high dose intravenous melphalanBritish Journal of Haematology, 1987
- Histologic Classification and Staging of Multiple Myeloma: A Retrospective and Prospective Study of 674 CasesAmerican Journal of Clinical Pathology, 1987
- Monoclonal B Lymphocytes in Multiple MyelomaScandinavian Journal of Immunology, 1980
- The effect of oxygen tension on haemopoietic and fibroblast cell proliferation in vitroJournal of Cellular Physiology, 1978
- The Monoclonal Nature of Lymphocytes in Multiple MyelomaAnnals of Internal Medicine, 1975
- Multiple Myeloma and Benign Monoclonal Gammopathy: Differentiation by Immunofluorescence of LymphocytesAnnals of Internal Medicine, 1973